Long-time collaborators Botond Roska and José-Alain Sahel win the Wolf Prize 2024 in the field of medicine
05 juil. 2024 03h00 HE
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Botond Roska and José-Alain Sahel have been awarded the Wolf Prize in Medicine for their pioneering work on restoring vision to blind patients using optogenetic therapy. The Wolf...
Long-time Collaborators Botond Roska and José-Alain Sahel Win International Prize for Translational Neuroscience
22 juin 2023 03h00 HE
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Basel, Switzerland, June 22, 2023 --In recognition of their pioneering work on restoring vision to blind patients using optogenetic therapy, Botond Roska and José-Alain Sahel were today awarded the...
Researchers Discover a New Embryonic Brain Circuit
13 avr. 2023 10h54 HE
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
EMBARGOED UNTIL 17-APR-2023 11:00 ET The findings may provide new insights into circuit abnormalities in autism. ...
New sequencing method developed at IOB has potential to become universal tool of choice
30 mai 2022 11h30 HE
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Media Release New sequencing method developed at IOB has potential to become universal tool of choice A new single-cell RNA-sequencing protocol developed at IOB enables the...
Das bewusstlose Gehirn ist alles andere als «stumm»
12 mai 2022 01h00 HE
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Die Grosshirnrinde gilt als zentrale Hirnregion für bewusste Verarbeitung. Während einer Vollnarkose wird dieser Bereich jedoch nicht lahmgelegt: Bestimmte Neurone zeigen dann sogar eine höhere...
Roska group researchers find: When unconscious, the brain is anything but ‘silent’
12 mai 2022 01h00 HE
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
The cerebral cortex is thought to be the seat of conscious processing in the brain. Rather than being inactivated, specific cells in the cortex show higher spontaneous activity during general...
Optogenetische Gentherapie lässt Erblindeten partiell wieder Sehen
24 mai 2021 11h00 HE
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Ein internationales Forschungsteam konnte zeigen, dass eine optogenetische Gentherapie bei einem wegen erblicher Retinitis pigmentosa erblindeten Patienten dazu beiträgt, einen Teil der Sehkraft...
Optogenetic Methods Restore Partial Vision in a Blind Patient
24 mai 2021 11h00 HE
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
An international research team has shown that optogenetic therapy has helped to partially regain visual function in a patient with retinitis pigmentosa. This is a milestone towards a gene therapy that...